STOCK TITAN

Inspire Medical Systems Inc - INSP STOCK NEWS

Welcome to our dedicated news page for Inspire Medical Systems (Ticker: INSP), a resource for investors and traders seeking the latest updates and insights on Inspire Medical Systems.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Inspire Medical Systems's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Inspire Medical Systems's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
none
-
Rhea-AI Summary
Inspire Medical Systems, Inc. will participate in the Wells Fargo 2023 Medtech Innovation Spotlight Series on May 22, 2023. The presentation will be accessible via a live webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.84%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.96%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.96%
Tags
conferences
-
Rhea-AI Summary
Inspire Medical Systems, Inc. (NYSE: INSP) reported an 84% increase in revenue for the first quarter of 2023, reaching $127.9 million. The company achieved a gross margin of 84.4% and activated 68 new centers in the U.S. during the quarter. They also created 17 new U.S. sales territories. Inspire received FDA approval for pediatric patients with Down syndrome and finalized countrywide reimbursement in Belgium. The company raised its full year 2023 revenue guidance to between $580 million to $590 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.96%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.18%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.63%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.18%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.76%
Tags
none
Inspire Medical Systems Inc

NYSE:INSP

INSP Rankings

INSP Stock Data

7.02B
29.05M
1.91%
104.24%
6.86%
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Professional, Scientific, and Technical Services
Link
US
Golden Valley

About INSP

inspire medical systems, inc. is a medical devices company based out of 9700 63rd avenue north suite 200, maple grove, minnesota, united states.